Onkológia S1/2019
Enzalutamide in the treatment of metastatic castration-resistant prostate cancer
Purpose: Prostate cancer is one of the most common malignant diseases by men. We can see new molecules in the treatment of metastatic disease, that allow to prolong overall survival. In this casuistic we want to show using of enzalutamide in the treatment of metastatic castration-resistant prostate cancer Case: We want to demonstrate the case of patient with metastatic castration – resistant prostate carcinoma treated with enzalutamide. Conclusion: This case confirmes significant therapeutic efficacy of enzalutamide.
Keywords: metastatic castration-resistant prostate cancer, docetaxel, enzalutamide
